Curasight welcomes international radiopharma experts to the board

2026-03-26 11:27:00

Following its Annual General Meeting, Curasight has announced changes to its Board of Directors. As Lars Trolle and Charlotte Vedel step down, the company welcomes Dr Marcel Reichen and Dr Colin Hayward as new board members. The additions aim to expand the board's international expertise within the radiopharmaceutical space as the company approaches key clinical milestones. BioStock contacted CEO Ulrich Krasilnikoff to learn more.

Read the full interview at biostock.se:

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook! 

About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.